Loading…
Loading…
are there any regions where you are losing share in toxins or fillers
if you could outline your next steps with your CAR-T and your oral peptide platforms
Could you just update us on your latest expectations for conversion from IV to subcutaneous and the kind of pace
comment on some of the changes we're seeing within the FDA and the HHS particularly, with reference to vaccines
could you just add a bit more color around what you're targeting for cholesterol lower, whether we might need to see